VRESKEZ Trademark

Trademark Overview


On Friday, November 10, 2023, a trademark application was filed for VRESKEZ with the United States Patent and Trademark Office. The USPTO has given the VRESKEZ trademark a serial number of 79385524. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2024. This trademark is owned by Novartis AG. The VRESKEZ trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
vreskez

General Information


Serial Number79385524
Word MarkVRESKEZ
Filing DateFriday, November 10, 2023
Status700 - REGISTERED
Status DateTuesday, July 30, 2024
Registration Number7459375
Registration DateTuesday, July 30, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, January 18, 2024ASSIGNED TO EXAMINER
Thursday, December 14, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Friday, December 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 15, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, December 19, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, January 24, 2024NON-FINAL ACTION WRITTEN
Thursday, January 25, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 5, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, February 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 13, 2024NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Friday, April 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, October 31, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB